Citation(s)
- Lin CC, Doi T, Muro K, Hou MM, Esaki T, Hara H, Chung HC, Helwig C, Dussault I, Osada M, Kondo S
Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGFß and PD-L1, in Patients with Esophageal Squamous Cell Carcinoma: Results from a Phase 1 Cohort i
- Yoo C, Oh DY, Choi HJ, Kudo M, Ueno M, Kondo S, Chen LT, Osada M, Helwig C, Dussault I, Ikeda M
Phase I study of bintrafusp alfa, a bifunctional fusion protein targeting TGF-ß and PD-L1, in patients with pretreated biliary tract cancer. J Immunother Canc
A Phase I, Open-label, Multiple-ascending Dose Trial to Investigate the Safety, Tolerability, Pharmacokinetics, Biological and Clinical Activity of MSB0011359C (M7824) in Subjects With Metastatic or Locally Advanced Solid Tumors With Expansion to Selected Indications in Asia
Details for clinical trial NCT02699515